Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms
Pharmaceuticals · 02.05.2023 · 16 (5) · 687
DOI: 10.3390/ph16050687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 02.05.2023. Verfasst von Hamna Batool Hashmi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan 29050, Pakistan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA) is among the leading causes of nosocomial infections and forms biofilms, which are difficult to eradicate because of their increasing resistance to antimicrobial agents. This is especially true for pre-existing biofilms. The current study focused on evaluating the efficacy of three β-lactam drugs, meropenem, piperacillin, and tazobactam, alone and in combination against the MRSA biofilms. When used individually, none of the drugs exhibited significant antibacterial activity against MRSA in a planktonic state. At the same time, the combination of meropenem, piperacillin, and tazobactam showed a 41.7 and 41.3% reduction in planktonic bacterial cell growth, respectively. These drugs were further assessed for biofilm inhibition and removal. The combination of meropenem, piperacillin, and tazobactam caused 44.3% biofilm inhibition, while the rest of the combinations did not show any significant effects. Results also revealed that piperacillin and tazobactam exhibited the best synergy against the pre-formed biofilm of MRSA, with 46% removal. However, adding meropenem to the piperacillin and tazobactam combination showed a slightly reduced activity towards the pre-formed biofilm of MRSA and removed 38.7% of it. Although the mechanism of synergism is not fully understood, our findings suggest that these three β-lactam drugs can be used in combination as very effective therapeutic agents for the treatment of pre-existing MRSA biofilms. The in vivo experiments on the antibiofilm activity of these drugs will pave the way for applying such synergistic combinations to clinics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan 29050, Pakistan.
- Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University, Shanghai 200062, China.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
- Nanocarriers Research Laboratory, Gomal Centre of Pharmaceutical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.
- Department of Pharmacy, Kohat University of Science and Technology, Kohat 26000, Pakistan.
- Department of Obstetrics and Gynecology, Gomal Medical College, Dera Ismail Khan 29050, Pakistan.
ORCID-Profile: Muhammad Asad Farooq, Abdulrahman Alshammari, Sheikh Abdur Rashid, Nauman Rahim Khan, Mohammad S Mubarak
Förderung
- King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
Hashmi, H. B., Farooq, M. A., Khan, M. H., Alshammari, A., Aljasham, A. T., Rashid, S. A., Khan, N. R., Hashmi, I. B., Badar, M., & Mubarak, M. S. (2023). Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms. Pharmaceuticals, 16(5), 687. https://doi.org/10.3390/ph16050687
Vancouver
Hashmi HB, Farooq MA, Khan MH, Alshammari A, Aljasham AT, Rashid SA, et al. Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms. Pharmaceuticals. 2023;16(5):687. doi:10.3390/ph16050687
BibTeX
@article{Hashmi2023,
author = {Hashmi, Hamna Batool and Farooq, Muhammad Asad and Khan, Muhammad Hashim and Alshammari, Abdulrahman and Aljasham, Alanoud T and Rashid, Sheikh Abdur and Khan, Nauman Rahim and Hashmi, Irum Batool and Badar, Muhammad and Mubarak, Mohammad S},
title = {Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {5},
pages = {687},
doi = {10.3390/ph16050687}
}
EUVIMED